Sinar Eka Selaras Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Sinar Eka Selaras Tbk. trades at Rp284 (market cap 1.47T, 501.8K 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp256 (market cap 715.5B, 30.64M 24h volume). The key difference: Sinar Eka Selaras Tbk. is far larger — about 2.1× Charlie Hospital Semarang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (30.64M versus 501.8K). Which is the better fit depends on your goals.
| ERAL | RSCH | |
|---|---|---|
Market Cap | 1.47T | 715.5B |
Volume | 501.8K | 30.64M |
Lot | 5.02K | 306.41K |
Turnover | 141.93M | 7.98B |
Average Price | 282.83 | 260.34 |
Value | 141.93M | 7.98B |
Indicative Equilibrium Price | 284 | 256 |
Indicative Equilibrium Volume | 10 | 512 |
Trailing returns across standard periods
Latest headlines on both assets
PT Sinar Eka Selaras Tbk (the “Company”) was established in Indonesia based on Notarial Deed No. 12 of Myra Yuwono, S.H., dated March 13, 2009. PT Erajaya Swasembada Tbk, an entity incorporated in Indonesia, is the parent company of the Company. PT Eralink International, an entity incorporated inIndonesia, is the ultimate parent of the Company.
Read more on ERAL →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →